BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 28881292)

  • 1. Exceptionally high UBE2C expression is a unique phenomenon in basal-like type breast cancer and is regulated by BRCA1.
    Qin T; Huang G; Chi L; Sui S; Song C; Li N; Sun S; Li N; Zhang M; Zhao Z; Li L; Li M
    Biomed Pharmacother; 2017 Nov; 95():649-655. PubMed ID: 28881292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. (-)-Epigallocatechin-3-gallate downregulates Pg-P and BCRP in a tamoxifen resistant MCF-7 cell line.
    Farabegoli F; Papi A; Bartolini G; Ostan R; Orlandi M
    Phytomedicine; 2010 Apr; 17(5):356-62. PubMed ID: 20149610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preliminary study of the effects of β-elemene on MCF-7/ADM breast cancer stem cells.
    Dong Y; Li L; Wang L; Zhou T; Liu JW; Gao YJ
    Genet Mol Res; 2015 Mar; 14(1):2347-55. PubMed ID: 25867381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversal of multidrug resistance by Marsdenia tenacissima and its main active ingredients polyoxypregnanes.
    To KKW; Wu X; Yin C; Chai S; Yao S; Kadioglu O; Efferth T; Ye Y; Lin G
    J Ethnopharmacol; 2017 May; 203():110-119. PubMed ID: 28363522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The phytoestrogen genistein enhances multidrug resistance in breast cancer cell lines by translational regulation of ABC transporters.
    Rigalli JP; Tocchetti GN; Arana MR; Villanueva SS; Catania VA; Theile D; Ruiz ML; Weiss J
    Cancer Lett; 2016 Jun; 376(1):165-72. PubMed ID: 27033456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Regulation mechanism of breast cancer resistance protein by toremifene to reverse BCRP-mediated multidrug resistance in breast cancer cells].
    Zhang YH; Li G; Yu J; Xu MS; Liu ZX
    Zhonghua Zhong Liu Za Zhi; 2011 Sep; 33(9):654-60. PubMed ID: 22340044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxidative Stress Promotes Doxorubicin-Induced Pgp and BCRP Expression in Colon Cancer Cells Under Hypoxic Conditions.
    Pinzón-Daza ML; Cuellar-Saenz Y; Nualart F; Ondo-Mendez A; Del Riesgo L; Castillo-Rivera F; Garzón R
    J Cell Biochem; 2017 Jul; 118(7):1868-1878. PubMed ID: 28106284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of ubiquitin conjugating enzyme UBE2C reduces proliferation and sensitizes breast cancer cells to radiation, doxorubicin, tamoxifen and letrozole.
    Rawat A; Gopal G; Selvaluxmy G; Rajkumar T
    Cell Oncol (Dordr); 2013 Dec; 36(6):459-67. PubMed ID: 24072565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acyl-CoA synthetase-4 is implicated in drug resistance in breast cancer cell lines involving the regulation of energy-dependent transporter expression.
    Orlando UD; Castillo AF; Medrano MAR; Solano AR; Maloberti PM; Podesta EJ
    Biochem Pharmacol; 2019 Jan; 159():52-63. PubMed ID: 30414939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RNA expression of breast cancer resistance protein, lung resistance-related protein, multidrug resistance-associated proteins 1 and 2, and multidrug resistance gene 1 in breast cancer: correlation with chemotherapeutic response.
    Burger H; Foekens JA; Look MP; Meijer-van Gelder ME; Klijn JG; Wiemer EA; Stoter G; Nooter K
    Clin Cancer Res; 2003 Feb; 9(2):827-36. PubMed ID: 12576456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ΔNp73 regulates the expression of the multidrug-resistance genes ABCB1 and ABCB5 in breast cancer and melanoma cells - a short report.
    Sakil HAM; Stantic M; Wolfsberger J; Brage SE; Hansson J; Wilhelm MT
    Cell Oncol (Dordr); 2017 Dec; 40(6):631-638. PubMed ID: 28677036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of ABC-cassette transporters (MDR1, MRP1, BCRP) in the development of primary and acquired multiple drug resistance in patients with early and metastatic breast cancer.
    Kovalev AA; Tsvetaeva DA; Grudinskaja TV
    Exp Oncol; 2013 Dec; 35(4):287-90. PubMed ID: 24382439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ATP-dependent activity and mitochondrial localization of drug efflux pumps in doxorubicin-resistant breast cancer cells.
    Dartier J; Lemaitre E; Chourpa I; Goupille C; Servais S; Chevalier S; Mahéo K; Dumas JF
    Biochim Biophys Acta Gen Subj; 2017 May; 1861(5 Pt A):1075-1084. PubMed ID: 28214549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Guggulsterone and bexarotene induce secretion of exosome-associated breast cancer resistance protein and reduce doxorubicin resistance in MDA-MB-231 cells.
    Kong JN; He Q; Wang G; Dasgupta S; Dinkins MB; Zhu G; Kim A; Spassieva S; Bieberich E
    Int J Cancer; 2015 Oct; 137(7):1610-20. PubMed ID: 25833198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-181a enhances drug sensitivity in mitoxantone-resistant breast cancer cells by targeting breast cancer resistance protein (BCRP/ABCG2).
    Jiao X; Zhao L; Ma M; Bai X; He M; Yan Y; Wang Y; Chen Q; Zhao X; Zhou M; Cui Z; Zheng Z; Wang E; Wei M
    Breast Cancer Res Treat; 2013 Jun; 139(3):717-30. PubMed ID: 23780685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The roles of four multi-drug resistance proteins in hepatocellular carcinoma multidrug resistance.
    Li G; Chen X; Wang Q; Xu Z; Zhang W; Ye L
    J Huazhong Univ Sci Technolog Med Sci; 2007 Apr; 27(2):173-5. PubMed ID: 17497289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ATP-binding cassette proteins BCRP, MRP1 and P-gp expression and localization in the human umbilical cord.
    Riches Z; Walia G; Berman JM; Wright TE; Collier AC
    Xenobiotica; 2016; 46(6):548-56. PubMed ID: 26407213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptional modulation of BCRP gene to reverse multidrug resistance by toremifene in breast adenocarcinoma cells.
    Zhang Y; Wang H; Wei L; Li G; Yu J; Gao Y; Gao P; Zhang X; Wei F; Yin D; Zhou G
    Breast Cancer Res Treat; 2010 Oct; 123(3):679-89. PubMed ID: 19967559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of ABCC1 and ABCG2 proteins by ouabain in human breast cancer cells.
    DA Silva VA; DA Silva KA; Delou JM; DA Fonseca LM; Lopes AG; Capella MA
    Anticancer Res; 2014 Mar; 34(3):1441-8. PubMed ID: 24596392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sensitization of ABCG2-overexpressing cells to conventional chemotherapeutic agent by sunitinib was associated with inhibiting the function of ABCG2.
    Dai CL; Liang YJ; Wang YS; Tiwari AK; Yan YY; Wang F; Chen ZS; Tong XZ; Fu LW
    Cancer Lett; 2009 Jun; 279(1):74-83. PubMed ID: 19232821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.